Indication

Cirrhosis Advanced

1 clinical trial

1 product

Clinical trial

Liver Cirrhosis Network (LCN) Rosuvastatin Efficacy and Safety for Cirrhosis in the United States (RESCU): A Double-Blind Randomized, Placebo-Controlled Phase 2 Study

Status: Recruiting, Estimated PCD: 2026-11-01

Product